The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Metastatic Colorectal Cancer Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
The global Metastatic Colorectal Cancer Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Metastatic Colorectal Cancer Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Cancer Research Centers,, are propelling Metastatic Colorectal Cancer Treatment market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metastatic Colorectal Cancer Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metastatic Colorectal Cancer Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metastatic Colorectal Cancer Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metastatic Colorectal Cancer Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metastatic Colorectal Cancer Treatment covered in this report include Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech and EMD Serono, etc.
The global Metastatic Colorectal Cancer Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Global Metastatic Colorectal Cancer Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metastatic Colorectal Cancer Treatment market, Segment by Type:
Surgery
Chemotherapy
Global Metastatic Colorectal Cancer Treatment market, by Application
Hospitals
Clinics
Cancer Research Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metastatic Colorectal Cancer Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
The global Metastatic Colorectal Cancer Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Metastatic Colorectal Cancer Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Cancer Research Centers,, are propelling Metastatic Colorectal Cancer Treatment market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metastatic Colorectal Cancer Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metastatic Colorectal Cancer Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metastatic Colorectal Cancer Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metastatic Colorectal Cancer Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metastatic Colorectal Cancer Treatment covered in this report include Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech and EMD Serono, etc.
The global Metastatic Colorectal Cancer Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Global Metastatic Colorectal Cancer Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metastatic Colorectal Cancer Treatment market, Segment by Type:
Surgery
Chemotherapy
Global Metastatic Colorectal Cancer Treatment market, by Application
Hospitals
Clinics
Cancer Research Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metastatic Colorectal Cancer Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Metastatic Colorectal Cancer Treatment
1.1 Metastatic Colorectal Cancer Treatment Market Overview
1.1.1 Metastatic Colorectal Cancer Treatment Product Scope
1.1.2 Metastatic Colorectal Cancer Treatment Market Status and Outlook
1.2 Global Metastatic Colorectal Cancer Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Metastatic Colorectal Cancer Treatment Market Size by Region (2018-2029)
1.4 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Region (2018-2023)
1.5 Global Metastatic Colorectal Cancer Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Metastatic Colorectal Cancer Treatment Market Size (2018-2029)
1.6.1 North America Metastatic Colorectal Cancer Treatment Market Size (2018-2029)
1.6.2 Europe Metastatic Colorectal Cancer Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size (2018-2029)
1.6.4 Latin America Metastatic Colorectal Cancer Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size (2018-2029)
2 Metastatic Colorectal Cancer Treatment Market by Type
2.1 Introduction
2.1.1 Surgery
2.1.2 Chemotherapy
2.2 Global Metastatic Colorectal Cancer Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Metastatic Colorectal Cancer Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Metastatic Colorectal Cancer Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Metastatic Colorectal Cancer Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Metastatic Colorectal Cancer Treatment Revenue Breakdown by Type (2018-2029)
3 Metastatic Colorectal Cancer Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Cancer Research Centers
3.2 Global Metastatic Colorectal Cancer Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Metastatic Colorectal Cancer Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Metastatic Colorectal Cancer Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Metastatic Colorectal Cancer Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Metastatic Colorectal Cancer Treatment Revenue Breakdown by Application (2018-2029)
4 Metastatic Colorectal Cancer Treatment Competition Analysis by Players
4.1 Global Metastatic Colorectal Cancer Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2022)
4.3 Date of Key Players Enter into Metastatic Colorectal Cancer Treatment Market
4.4 Global Top Players Metastatic Colorectal Cancer Treatment Headquarters and Area Served
4.5 Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Metastatic Colorectal Cancer Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.1.4 Sanofi Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.2.4 Roche Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Profile
5.3.2 Eli Lilly Main Business
5.3.3 Eli Lilly Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.3.4 Eli Lilly Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.4.4 Pfizer Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.5.4 Novartis Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.6.4 Amgen Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Taiho Oncology
5.7.1 Taiho Oncology Profile
5.7.2 Taiho Oncology Main Business
5.7.3 Taiho Oncology Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.7.4 Taiho Oncology Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Taiho Oncology Recent Developments
5.8 Genentech
5.8.1 Genentech Profile
5.8.2 Genentech Main Business
5.8.3 Genentech Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.8.4 Genentech Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Genentech Recent Developments
5.9 EMD Serono
5.9.1 EMD Serono Profile
5.9.2 EMD Serono Main Business
5.9.3 EMD Serono Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.9.4 EMD Serono Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 EMD Serono Recent Developments
5.10 Suzhou Zelgen Biopharmaceuticals
5.10.1 Suzhou Zelgen Biopharmaceuticals Profile
5.10.2 Suzhou Zelgen Biopharmaceuticals Main Business
5.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Products, Services and Solutions
5.10.4 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Suzhou Zelgen Biopharmaceuticals Recent Developments
6 North America
6.1 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Metastatic Colorectal Cancer Treatment Market Dynamics
11.1 Metastatic Colorectal Cancer Treatment Industry Trends
11.2 Metastatic Colorectal Cancer Treatment Market Drivers
11.3 Metastatic Colorectal Cancer Treatment Market Challenges
11.4 Metastatic Colorectal Cancer Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
